Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The lotion and cream categories are fundamental in skincare, primarily used for moisturizing and nourishing the skin, with distinctions based on texture, oil content, and suitable skin types/seasons [7] - Moisturizing remains the core demand with a 31% share, but its growth rate is stable at 5%, indicating a mature stage with limited growth potential. Nourishing creams, although only 5% of the market, show the highest growth rate at 16%, indicating a rising demand for high-nutrition lotions and creams [9][10] - The market is experiencing a shift, with a notable decline in demand for soothing, firming, and anti-wrinkle products, suggesting a saturation of these categories [9][10] Market Trends - The online sales landscape is shifting, with Douyin's sales share increasing from 44% to 49% and volume share from 47% to 67% between 2023 and 2025, while Tmall's shares are declining [16][22] - The average price on Tmall has risen significantly, while Douyin's average price dropped sharply, indicating a strategy focused on volume through lower pricing [15][20] - The overall market growth is slowing, with a projected sales growth of only 4.3% from 2024 to 2025, suggesting that companies need to adapt to channel characteristics [22] Competitive Landscape - The top brands on Tmall are dominated by high-end products, with significant sales figures, while Douyin shows a more fragmented market with rapid growth among new brands [24][26] - Domestic brands are leading in low-price, high-volume segments, while international brands maintain a high-price, low-volume strategy [26] - The report highlights the importance of product differentiation and the need for brands to focus on emerging trends and consumer demands to capture market share [11][12] Consumer Behavior - There is a significant demand for products targeting sensitive skin and repair, which are identified as "blue ocean" opportunities due to supply shortages [11] - The report indicates that high-demand, low-supply segments present opportunities for growth, while high-supply, low-demand segments require careful evaluation [12] Brand Strategies - Brands are increasingly leveraging live streaming and influencer partnerships to enhance visibility and sales, with a notable shift towards using influencers to reach broader audiences [50][57] - The report emphasizes the importance of maintaining a balance between high-end positioning and market penetration through various pricing strategies [41][42]

Core Viewpoint - The cosmetic industry faces its first IPO termination case in 2026, as Chuang'er Bio announces the cessation of its listing guidance due to unresolved shareholder equity freeze issues, marking its second failed IPO attempt [1][3][11]. Group 1: IPO Termination Reasons - The termination of the IPO guidance is attributed to the long-term unresolved issue of shareholder equity freeze, particularly involving the second-largest shareholder Ding Yumei, whose shares are frozen due to legal actions related to Evergrande's debt crisis [3][5][8]. - The company had previously attempted to go public, facing setbacks including two failed applications to the Sci-Tech Innovation Board and a subsequent shift to the Beijing Stock Exchange, which also did not yield results [10][11]. Group 2: Financial Performance and Challenges - Chuang'er Bio has struggled with fluctuating financial performance, with revenue consistently hovering between 240 million and 400 million RMB over the past six years, indicating a clear growth ceiling [12][14]. - The company's revenue for 2025 was reported at 214 million RMB for the first half, reflecting a year-on-year increase of 16.98%, but net profit plummeted by 55.99% to 13.21 million RMB, highlighting a trend of "increased revenue without increased profit" [13][14]. Group 3: Industry Context and Competitive Landscape - The collagen market is projected to surpass hyaluronic acid, becoming the leading ingredient in skincare by 2025, with a forecasted market size of 108.3 billion RMB by 2027, growing at a compound annual growth rate of 42.4% [16]. - Competitors like Juzhi Bio and Jinbo Bio have significantly outpaced Chuang'er Bio in both revenue and profitability, with Juzhi Bio's revenue soaring from 2.36 billion RMB in 2022 to 5.54 billion RMB in 2024, while Chuang'er Bio's growth remains stagnant [17][20]. Group 4: Regulatory and Technological Challenges - Regulatory tightening and the decline of the "medical device" business model have adversely affected Chuang'er Bio, which previously relied on its medical dressing products for competitive advantage [18]. - The shift in technology from animal-derived collagen to recombinant collagen has created a gap, with competitors advancing in this area while Chuang'er Bio remains focused on traditional collagen products [19][20]. Group 5: Future Outlook - The termination of the IPO is seen as a culmination of long-standing issues in industry competition, technological positioning, and capital utilization, suggesting that Chuang'er Bio must find a sustainable growth engine and differentiate itself in a competitive landscape to consider future IPO attempts [21].

Core Viewpoint - The domestic beauty brand "Banmu Huatian" has submitted its listing application to the Hong Kong Stock Exchange, aiming to become the first domestic personal care stock in Hong Kong, with CITIC Securities as its sponsor [2] Group 1: Company Overview - Banmu Huatian's parent company, Shandong Huawutang Cosmetics Co., Ltd., was established in 2018 and operates as a full industry chain brand focusing on body care, with R&D centers in Jinan, Shanghai, and Guangzhou [2] - The company has completed two rounds of financing, attracting attention from industry players like Marubi and Lin Qingxuan [2] - According to the prospectus, Huawutang is projected to achieve revenues of 1.199 billion yuan and 1.499 billion yuan in 2023 and 2024, respectively, with adjusted net profits of 23.7 million yuan and 82.8 million yuan [2] Group 2: Product Performance - Banmu Huatian's product lines include body care, hair care, and facial care, with body and facial care accounting for over 80% of revenue in 2024 [3] - Hair care products saw significant growth, with revenue increasing from 80.884 million yuan to 482 million yuan, a 496% increase, and their revenue share rising from 7.5% to 25.4% [3][9] Group 3: Market Trends - In 2023, domestic beauty brands captured 50.4% of the market share, surpassing foreign brands for the first time, and this is expected to rise to 55.2% in 2024 [4] - Over 90% of Gen Z consumers have chosen domestic beauty brands, with nearly all post-2000 consumers having tried domestic brands [4][5] Group 4: Brand Strategy - Banmu Huatian has effectively engaged with young consumers by signing influential celebrity endorsements, which has significantly boosted its brand recognition and sales [5] - The company has established a strong product ecosystem, with standout products like the "Whitening Body Lotion" and "Ice Cream Smooth Body Scrub" achieving substantial sales [8][9] Group 5: Supply Chain and Industry Position - The success of Banmu Huatian is attributed to its deep integration of the supply chain and industry chain, allowing for effective control over raw materials and production standards [6][7] - The company has established raw material plantations across more than 10 locations in China, enhancing its supply chain capabilities [6] Group 6: Future Outlook - The competitive landscape for domestic beauty brands is intensifying, with a focus on deepening supply chain collaboration as a core competitive advantage [7] - The ability to innovate in product development through supply chain synergy will be crucial for brands to succeed in the next market cycle [7][10]

Core Viewpoint - Cathay Securities initiates coverage on Lin Qingxuan (02657) with a "Buy" rating, highlighting the company's long-standing focus on oil-based skincare and its potential for sustained rapid growth driven by Douyin and product expansion [1] Group 1: Company Overview - Lin Qingxuan, founded in 2003, initially focused on natural skincare products like handmade soaps and aloe vera gel, and launched its flagship product, camellia oil essence, in 2014, establishing itself as a pioneer in oil-based skincare [1] - The company has a stable and experienced management team, and has recently accelerated its online transformation, with significant growth in revenue and net profit in the first half of 2025, achieving 10.5 million and 1.8 million RMB respectively, representing year-on-year increases of 98% and 110% [1] Group 2: Market Position and Growth Potential - The oil-based skincare segment is experiencing high demand, with the market size projected to reach 5.3 billion RMB in 2024, reflecting a year-on-year growth of 43% and a CAGR of 42% from 2019 to 2024 [2] - Lin Qingxuan has maintained a leading position in the facial essence oil category, holding a 12.4% market share in 2024, significantly ahead of other brands [2] Group 3: Sales and Distribution Channels - The company's flagship product, the camellia oil essence, has seen rapid growth, with revenue from this category increasing by 176% year-on-year in the first half of 2025, accounting for 46% of total revenue [3] - Online sales have surged, with Douyin driving a 137% year-on-year increase in online revenue, which now constitutes 65% of total sales; the company also has over 554 physical stores, indicating substantial room for further expansion [3]

Core Viewpoint - Cathay Securities initiates coverage on Lin Qingxuan (02657) with a "Buy" rating, highlighting the company's long-standing focus on oil-based skincare and the significant growth potential driven by Douyin and product expansion [1] Group 1: Company Overview - Lin Qingxuan, founded in 2003, initially focused on natural skincare products like handmade soaps and aloe vera gel, and launched its flagship product, camellia oil essence, in 2014, establishing itself as a pioneer in oil-based skincare [1] - The company has a stable and experienced management team, and its recent online transformation has led to accelerated growth, with H1 2025 revenue and net profit reaching 1.05 billion and 180 million RMB, respectively, representing year-on-year increases of 98% and 110% [1] Group 2: Market Position - The oil-based skincare segment is experiencing high demand, with the market size projected to reach 5.3 billion RMB in 2024, reflecting a year-on-year growth of 43% and a CAGR of 42% from 2019 to 2024 [2] - Lin Qingxuan has maintained a leading position in the facial essence oil category, holding a 12.4% market share in 2024, significantly ahead of other brands [2] Group 3: Growth Drivers - The company's flagship product, the camellia oil essence, has seen rapid growth, with H1 2025 revenue from this category increasing by 176%, accounting for 46% of total revenue [3] - Online sales have surged, with H1 2025 online revenue growing by 137%, making up 65% of total revenue, driven by Douyin's influence [3] - The company has a robust offline presence with over 554 stores as of H1 2025, indicating potential for further expansion and increased sales per store [3]

Core Viewpoint - China is enhancing its efforts to attract foreign investors through new policies that promote reinvestment of profits locally, offering tax breaks, expedited approvals, and improved business services [2][3]. Foreign Investment and Reinvestment - During the "14th Five-Year Plan," China attracted US$708.7 billion in foreign investment and established 229,000 new foreign enterprises [3]. - The "Measures to Encourage Foreign-Invested Enterprises to Reinvest in China" were introduced by the NDRC, Ministry of Finance, and Ministry of Commerce to support long-term investment growth [3]. Reinvestment Definition and Implications - Reinvestment involves foreign companies reinvesting their profits earned in China back into the local market for further growth [4]. - This can include launching new ventures, expanding existing operations, and acquiring shares or assets in Chinese companies [4]. Profit-Retention and Reinvestment Loop - The goal is to create a cycle where earnings remain in China, promoting expansion and unlocking benefits such as tax incentives and streamlined approvals [5]. Key Incentives for Foreign Investors - The new policy includes 12 measures to facilitate reinvestment, such as faster project approvals, simplified paperwork, flexible land-use options, tax credits of up to 10% for reinvested profits, easier foreign exchange and financing support, and priority access to high-tech industries [6][7][8][9][10]. Multinational Responses - Major multinationals are responding positively to these incentives, with examples including Lexus completing a new energy project in Shanghai in under five months, Vandewiele opening its largest manufacturing base in Jiangsu, and Weidmann Electrical Insulation launching a US$91 million plant in Wuhan [11][12][14]. - Executives express confidence in China's market prospects, highlighting the benefits of streamlined approvals and tax credits [15][16][17]. Focus on High-Tech and R&D - High-tech industries accounted for 34.6% of foreign investment in 2024, reflecting a six-point increase since 2020 [18]. - Multinationals are establishing R&D centers and regional headquarters to support local product development, with innovation clusters in cities like Shanghai, Shenzhen, and Wuhan driving growth in various sectors [19][20]. Financial Benefits and Policy Support - China's reinvestment framework offers financial benefits such as tax credits for reinvested profits, flexible land-use policies, and streamlined foreign exchange and financing services [22][23]. - Companies are leveraging these advantages to accelerate projects and drive sustainable growth, as seen in Otis's plans for elevator modernization and L'Oréal's investment in green manufacturing [24]. Strategic Timing for Reinvestment - With favorable tax incentives and support for key industries, China is positioning itself as a long-term growth hub for global companies [25]. - Reinvesting now allows businesses to reduce operational costs, access booming sectors, and establish local partnerships, thereby benefiting from China's evolving markets [26].

Group 1: Market Outlook - The core viewpoint is that China is entering a "transformation bull market," characterized by higher, more stable, and longer-lasting growth, with the Shanghai Composite Index showing strong performance since the beginning of 2026 [1] - The report emphasizes that the resolution of internal and external concerns by 2024 and 2025 respectively will lead to a reassessment of the Chinese stock market, fostering greater confidence and stability [1] - The three key drivers of the "transformation bull market" are the breaking of the implicit guarantee in Chinese society, the decline of risk-free returns, and capital market reforms [1] Group 2: Regulatory Environment - The China Securities Regulatory Commission (CSRC) has reiterated its commitment to maintaining a stable market environment, emphasizing the need to prevent large fluctuations and promote long-term investment [2] - The regulatory approach aims to direct funds towards high-quality assets, enhancing the investability of the Chinese capital market [2] - A stricter regulatory framework is seen as beneficial for the long-term sustainability of the market, allowing more investors to share in the benefits of economic transformation and reform [2] Group 3: Industry Comparisons - The report highlights optimism for technology sector leaders and the A500 index, driven by the stabilization of the Chinese economy and increasing asset management demands [3] - Key recommendations include focusing on technology growth, non-bank financials, and cyclical sectors, with specific mentions of semiconductor demand and the benefits of capital market reforms [3] - The report suggests that sectors such as food, retail, and tourism services will benefit from domestic demand expansion policies [3] Group 4: Thematic Recommendations - The report identifies several themes for investment, including domestic computing power, new energy grids, robotics, and domestic consumption [4] - It highlights the acceleration of capital expenditure in domestic AI model products and the expected growth in investments in smart grids and energy storage [4] - The tourism, hotel, and aviation sectors are expected to benefit from government initiatives to boost service consumption [4] Group 5: GEO Marketing Transformation - The introduction of Generative Engine Optimization (GEO) is set to transform marketing strategies, with a focus on optimizing content for AI recognition and recommendation [12][13] - GEO is expected to enhance marketing efficiency by shortening consumer decision-making processes and replacing traditional SEO methods [13] - Companies that adapt to the new flow of traffic and marketing strategies, particularly in AI and SaaS, are likely to benefit significantly from this transformation [14]

Core Viewpoint - PDRN is expected to be a popular skincare ingredient by 2026, with a projected CAGR of 49% in the Chinese market from 2023 to 2029, indicating rapid growth in demand for related products [2][5]. Group 1: PDRN Research and Development - The UNISKIN MED center has been providing various PDRN/PN treatments since 2020, accumulating nearly 6 years of clinical experience with over 10,000 cases [7]. - UNISKIN has developed a dual approach in functional skincare and professional medical aesthetics, enhancing its exploration in the PDRN research field [9]. - The company has introduced a PDRN skincare and medical treatment model, showing significant efficacy in various applications such as scar treatment and anti-aging [11]. Group 2: Scientific Standards and Regulations - UNISKIN, in collaboration with the Chinese Society of Plastic Surgery, launched the "PDRN/PN Cosmetics Application Specification" to standardize the quality and safety of PDRN/PN ingredients in skincare products [23]. - The specification addresses three major challenges in the PDRN sector: defining molecular weight, standardizing application amounts, and establishing detection methods for PDRN in cosmetics [24][27]. - The recommended addition of PDRN/PN raw materials is between 0.0001% and 1%, depending on specific conditions [25]. Group 3: Molecular Weight Control and Mechanisms - UNISKIN has developed the NeoEdge sequence cutting technology to precisely control PDRN molecular weight, creating the PDRN-850K core ingredient that activates five anti-aging pathways [16][19]. - The precise control of molecular weight is crucial for effective transdermal delivery and achieving the desired effects, addressing challenges such as low penetration efficiency and unclear mechanisms [14][20]. - The company emphasizes that effective PDRN application requires understanding the skin environment and controlling inflammation before activating systemic anti-aging pathways [13][19]. Group 4: Industry Position and Future Directions - UNISKIN's commitment to deep scientific research positions it as a leader in the PDRN market, providing a clear path for high-quality development in the industry [21][42]. - The establishment of industry standards signifies a maturation of the PDRN sector, allowing for more informed consumer choices and reducing the risks associated with unregulated growth [29][31]. - UNISKIN's innovative approach and rigorous research standards are expected to drive further exploration of PDRN's potential in skincare, highlighting the need for a more professional perspective in the industry [40][42].

Investment Rating - The report assigns an "Outperform" rating to multiple companies including Nike, Midea Group, JD Group, and Anta Sports, among others [1]. Core Insights - Concerns regarding the independence of the Federal Reserve and future monetary policy stability have led to a collective decline in overseas consumer sectors [4][11]. - The snack sector has shown resilience, outperforming the MSCI China index, while other sectors such as luxury goods and overseas sportswear have faced significant declines [4][11]. - The report highlights that most sectors are currently undervalued compared to their historical averages, indicating potential investment opportunities [9][15]. Sector Performance Summary - **Snack Sector**: Increased by 1.7%, with Wei Long's revenue guidance for 2026 projected to grow over 15% due to innovative products and channel expansion [6][14]. - **Jewelry Sector**: Rose by 1.6%, driven by Chow Tai Fook's strong operational performance expectations for FY26Q3 [6][14]. - **Overseas Cosmetics**: Gained 1.1%, with E.L.F Beauty's sales growth exceeding previous guidance [6][14]. - **Domestic Sportswear**: Increased by 1.5%, with Li Ning's revenue meeting expectations and a positive outlook for net profit margins [8][14]. - **Pet Sector**: Grew by 0.3%, with strong annual growth despite a slight decline in December [8][14]. - **Gambling Sector**: Slight decline of 0.1%, with Galaxy Entertainment showing resilience as a preferred investment choice [8][14]. - **Domestic Cosmetics**: Decreased by 0.3%, with expectations for recovery in 2026 [8][14]. - **Retail Sector**: Fell by 1.5%, with Target's positive leadership changes noted [8][14]. - **Luxury Goods**: Declined by 2.9%, impacted by market concerns over credit risks following Saks Global's bankruptcy [8][14]. - **Overseas Sportswear**: Experienced a significant drop of 4.0%, with major brands like Nike and Adidas facing declines [8][14]. - **Credit Card Sector**: Decreased by 5.1%, influenced by proposed caps on credit card interest rates [8][14]. Valuation Analysis - The report indicates that the expected PE ratios for various sectors in 2025 are below their historical averages, suggesting potential undervaluation: - Overseas Sportswear: 30.4x (57% of historical average) - Domestic Sportswear: 13.5x (71% of historical average) - Jewelry: 22.8x (43% of historical average) - Luxury Goods: 27.4x (49% of historical average) - Gambling: 16.2x (26% of historical average) - Overseas Cosmetics: 41.0x (61% of historical average) - Domestic Cosmetics: 27.3x (51% of historical average) - Pet Sector: 36.9x (50% of historical average) - Snack Sector: 29.8x (72% of historical average) - Retail: 29.9x (54% of historical average) - US Hotels: 34.8x (21% of historical average) - Credit Cards: 28.3x (54% of historical average) [9][15].

来源：雷递 雷递网 雷建平 1月18日 山东花物堂化妆品股份有限公司（简称："半亩花田"）日前递交招股书，准备在港交所上市。 9个月营收19亿 期内利润1.25亿 半亩花田成立于2010年，成立于中国'玫瑰之乡'山东济南，从诞生之初就致力于'花植'的研究，并确立 了'以花悦肤'的品牌理念。 半亩花田通过将玫瑰花水、牡丹籽油等天然花植成分融入核心配方，并持续推动配方技术升级，打造了 具有鲜明特色的身体洗护产品系列。 招股书显示，半亩花田2023年、2024年营收分别为12亿、15亿元；毛利分别为7.89亿、9.33亿元；期内 利润分别为2050万、4941万元。 | | | 截至12月31日止年度 | | | | 截至9月30日止九個月 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 2023 年 | | 2024年 | | 2024年 | | 2025年 | | | | 金額 | ﻲ | 金額 | 96 | 金額 | 96 | 金額 | 90 | | | | | | (除百分比外,單位:人民幣千元) | | | | | | | ...